IP Library Granted Patent US 5,932,571
Granted Patent Utility
US 5,932,571 · App. 09/036,155

Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases

Inventors: George D. Maynard, John M. Kane, Christopher R. Dalton, Braulio Santiago, Elizabeth M. Kudlacz, Larry D. Bratton
Patented Case View Patent ↗
Granted: Aug 3, 1999 Filed: Mar 6, 1998
Inventors
George D. Maynard
John M. Kane
Christopher R. Dalton
Braulio Santiago
Elizabeth M. Kudlacz
Larry D. Bratton
Assignee (at issue)
Hoechst Marion Roussel

This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.

Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 5,932,571
App. No.
09/036,155
Filed
1998-03-06
Granted
1999-08-03
Kind
A